Please assess the completion status of the following clinical trial:

Trial Title: Sequential HIV Therapy in Treatment Resistant HIV-1 Infected Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* HIV-1 infected patients~* At least 18 years of age~* Males or non-pregnant, non-lactating females~* Documented virological treatment failure on at least 3 classes of antiretroviral drugs~* No adequate antiretroviral therapy possible with currently available antiretroviral agents~* Virological treatment failure is defined as plasma HIV-1 RNA levels \> 5000 while taking at least three different antiretroviral drugs

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Continuous triple-class therapy (Type: ACTIVE_COMPARATOR): Patients will be treated with a regimen containing antiretroviral agents from 3 different classes
- Alternating therapy (Type: EXPERIMENTAL): Patients will be assigned to weekly alternating dual-class regimen

Based on this trial design, predict the completion outcome and termination type (if applicable).